Napodano, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 2.632
AS - Asia 1.871
EU - Europa 1.519
SA - Sud America 359
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 52
OC - Oceania 12
Totale 6.578
Nazione #
US - Stati Uniti d'America 2.538
SG - Singapore 936
SE - Svezia 429
CN - Cina 368
BR - Brasile 300
IT - Italia 288
DE - Germania 182
VN - Vietnam 164
FR - Francia 156
GB - Regno Unito 99
IE - Irlanda 99
IN - India 76
JP - Giappone 57
BD - Bangladesh 56
ID - Indonesia 53
RU - Federazione Russa 52
FI - Finlandia 47
CA - Canada 42
HK - Hong Kong 33
MX - Messico 31
PL - Polonia 25
ES - Italia 21
TR - Turchia 19
AR - Argentina 18
BE - Belgio 18
ZA - Sudafrica 18
IQ - Iraq 17
NL - Olanda 16
UA - Ucraina 16
KR - Corea 15
CO - Colombia 10
MA - Marocco 10
AT - Austria 9
CZ - Repubblica Ceca 9
AE - Emirati Arabi Uniti 8
IR - Iran 8
PK - Pakistan 8
CH - Svizzera 7
CI - Costa d'Avorio 7
EC - Ecuador 7
LT - Lituania 7
MY - Malesia 7
SA - Arabia Saudita 7
AU - Australia 6
BY - Bielorussia 6
CL - Cile 6
GR - Grecia 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
VE - Venezuela 6
DK - Danimarca 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CR - Costa Rica 4
DZ - Algeria 4
EG - Egitto 4
GY - Guiana 4
HN - Honduras 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
LB - Libano 4
PH - Filippine 4
PY - Paraguay 4
HU - Ungheria 3
KZ - Kazakistan 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
MM - Myanmar 2
NP - Nepal 2
PE - Perù 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MQ - Martinica 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
TH - Thailandia 1
Totale 6.444
Città #
Singapore 568
Chandler 383
Ashburn 285
San Jose 232
New York 131
Dublin 99
Beijing 96
Dallas 85
Rome 77
Los Angeles 70
Frankfurt am Main 56
Tokyo 54
Lauterbourg 52
Ho Chi Minh City 50
Jakarta 50
San Mateo 49
The Dalles 49
Munich 40
Boston 39
Helsinki 37
Hanoi 36
São Paulo 36
Princeton 35
Moscow 34
Hefei 33
Council Bluffs 32
Marseille 32
North Bergen 31
Hong Kong 30
Wilmington 30
Chicago 26
Milan 26
Orem 23
Fairfield 22
Houston 21
Cattolica 20
Santa Clara 20
Boardman 19
Nanjing 19
Da Nang 18
Chennai 16
Warsaw 16
Atlanta 15
Montreal 15
Redwood City 15
Bologna 14
Bremen 14
Castelnuovo di Val di Cecina 14
Dearborn 14
Falls Church 14
Johannesburg 14
Brussels 13
Buffalo 13
Denver 13
London 13
Poplar 13
Seattle 13
Stockholm 13
Jacksonville 12
Mexico City 12
Norwalk 12
San Francisco 12
Edinburgh 11
Hyderabad 11
Nuremberg 11
Seoul 11
Toronto 11
Brooklyn 10
Kent 10
Amsterdam 9
Bexley 9
Hebei 9
Paris 9
Woodbridge 9
Manchester 8
Phoenix 8
Querétaro 8
Rio de Janeiro 8
Shenyang 8
Abidjan 7
Ann Arbor 7
Augusta 7
Baghdad 7
Dhaka 7
Falkenstein 7
Guangzhou 7
Brno 6
Minsk 6
New Delhi 6
Roubaix 6
Shanghai 6
Tukwila 6
Auckland 5
Belo Horizonte 5
Charlotte 5
Curitiba 5
Düsseldorf 5
Lancaster 5
Palermo 5
Wroclaw 5
Totale 3.630
Nome #
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 202
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 172
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 172
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 169
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 167
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 165
Immunological role of IgG subclasses 161
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 159
Evaluation of screening method for Bence Jones protein analysis 157
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 151
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 150
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 147
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 145
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 143
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 143
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 142
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 139
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 137
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 137
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 137
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 136
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 134
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 131
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 131
Immunological role of IgG subclasses 129
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 128
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 128
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 127
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 127
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 124
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 124
The Laboratory Role in anti-TNF Biological Therapy Era 122
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 122
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 118
Serum free light chain quantitative assays: Dilemma of a biomarker 113
Heavy chain disease: Our experience 111
IgG cryoglobulinemia 110
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 106
COVID-19, adaptative immune response and metabolic-associated liver disease 106
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 105
The dark side of current analytic methods for Bence Jones Proteinuria 105
Cryoglobulins: putative effectors of adaptive immune response 104
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 103
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 102
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 102
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 99
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 96
Free light chains and autoimmunity 90
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 83
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 82
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 72
Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort 8
Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver disease 5
Totale 6.578
Categoria #
all - tutte 29.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.073


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022385 0 2 5 69 30 16 11 62 20 16 65 89
2022/20231.131 177 145 74 168 67 118 71 89 119 17 63 23
2023/2024581 31 144 8 54 15 107 46 24 8 25 52 67
2024/20251.144 53 37 83 46 102 52 21 60 172 110 217 191
2025/20262.794 360 57 203 393 532 140 490 130 158 172 75 84
2026/2027142 115 27 0 0 0 0 0 0 0 0 0 0
Totale 6.578